<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="26661">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01803815</url>
  </required_header>
  <id_info>
    <org_study_id>NOVA - CEDOC/FCT</org_study_id>
    <nct_id>NCT01803815</nct_id>
  </id_info>
  <brief_title>Evaluation of Antihypertensive Drugs in OSA Patients</brief_title>
  <acronym>ADOSA</acronym>
  <official_title>Evaluation of Antihypertensive Drugs in Patients With Obstructive Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Nova de Lisboa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidade Nova de Lisboa</source>
  <oversight_info>
    <authority>Portugal: Ethics Committee for Clinical Research</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective cohort study aimed to assess the phenotypic characteristics of OSA patients
      and their pattern of antihypertensive drugs consumption. The investigators also aimed to
      investigate a hypothetical association between ongoing anti-hypertensive regimen and Blood
      pressure control rates in these patients. Additionally, the investigators were also
      interested in trying to understand if the control of OSA may be influenced by the use of
      different classes of anti-hypertensive drugs.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2010</start_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Number of participants with uncontrolled BP before CPAP (Continuous Positive Airway Pressure) adaptation.</measure>
    <time_frame>patients will be followed up for an expected average time of 2 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">369</enrollment>
  <condition>Hypertension</condition>
  <condition>Obstructive Sleep Apnea</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients, male and women, aged above 18 years, that attended a first visit at
        CHLN Hospital Sleep Unit, located in Lisbon, were enrolled.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aged above 18 years, that attended a first visit at CHLN Hospital Sleep Unit were
             enrolled

        Exclusion Criteria:

          -  severe psychiatric disease or inability to understand the information required for an
             informed consent.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lucilia N Diogo, PharmD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidade Nova de Lisboa - CEDOC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paula Pinto, PhD, MD</last_name>
    <role>Study Chair</role>
    <affiliation>CHLN</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cristina Bárbara, PhD, MD</last_name>
    <role>Study Chair</role>
    <affiliation>CHLN</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Emilia C Monteiro, PhD, MD</last_name>
    <role>Study Director</role>
    <affiliation>Universidade Nova de Lisboa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ana L Papoila, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Universidade Nova de Lisboa</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universidade Nova de Lisboa - Faculdade de Ciências Médicas</name>
      <address>
        <city>Lisboa</city>
        <zip>1169-056</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <link>
    <url>http://www.fcm.unl.pt/main/</url>
    <description>Universidade Nova de Lisboa - Faculdade de Ciências Médicas</description>
  </link>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 1, 2013</lastchanged_date>
  <firstreceived_date>February 27, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>obstructive sleep apnea</keyword>
  <keyword>hypertension</keyword>
  <keyword>antihypertensive drugs</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Antihypertensive Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
